{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T05:42:18Z","timestamp":1769319738529,"version":"3.49.0"},"reference-count":15,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2014,7,26]],"date-time":"2014-07-26T00:00:00Z","timestamp":1406332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2014,7,26]],"date-time":"2014-07-26T00:00:00Z","timestamp":1406332800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["aornjournal.org","nursingconsult.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AORN Journal"],"published-print":{"date-parts":[[2014,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:label\/><jats:p>Perioperative hemostasis, the effective management of bleeding during operative and other invasive procedures, can involve the use of blood, blood products, and hemostatic agents to augment the patient's natural clotting abilities. Currently, more than 50 hemostatic products are available in the marketplace and dozens more are in development. It is important for perioperative nurses to understand each of the hemostatic agent categories and their actions, properties, applications, and limitations. This article provides an overview of the normal coagulation process (ie, clotting cascade) that is activated by the body when there is a bleeding episode; the management of blood products and the rationale for reducing their use; the financial implications of hemostatic agent use; and how these agents are used, their clinical indications, and potential complications from their use.<\/jats:p><\/jats:sec>","DOI":"10.1016\/j.aorn.2014.01.024","type":"journal-article","created":{"date-parts":[[2014,7,26]],"date-time":"2014-07-26T17:45:21Z","timestamp":1406396721000},"page":"131-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Hemostatic Agents: A Guide to Safe Practice for Perioperative Nurses"],"prefix":"10.1002","volume":"100","author":[{"given":"Margaret A.","family":"Camp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,7,26]]},"reference":[{"issue":"4","key":"e_1_2_9_2_2","first-page":"593","article-title":"Clinical use of topical thrombin as a surgical hemostat","volume":"2","author":"Lew W.","year":"2008","journal-title":"Biologics"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.01703.x"},{"key":"e_1_2_9_4_2","unstructured":"St Peter E Kneedler J.Hemostasis[AORN Independent Study Guide]. Presented at: AORN Congress; March 2\u20107 2013; San Diego CA."},{"key":"e_1_2_9_5_2","volume-title":"Management of Surgical Hemostasis: An Independent Study Guide","author":"Moss R.","year":"2013"},{"issue":"76","key":"e_1_2_9_6_2","first-page":"1","article-title":"Management of bleeding and coagulopathy following major trauma: an updated European guideline","volume":"17","author":"Spahn D.R.","year":"2013","journal-title":"Crit Care"},{"issue":"5","key":"e_1_2_9_7_2","first-page":"1","article-title":"Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution","volume":"113","author":"Bollinger D.","year":"2010","journal-title":"Anesthesiology"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-2092(08)00586-3"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.4103\/0974-2700.76844"},{"key":"e_1_2_9_10_2","first-page":"135","article-title":"Thrombin use in surgery: an evidence\u2010based review of clinical use","volume":"1","author":"Ham S.W.","year":"2010","journal-title":"J Blood Med"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.aorn.2013.12.012"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2008.01.001"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/1076029610363589"},{"issue":"8","key":"e_1_2_9_14_2","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.avsg.2011.07.009","article-title":"OMNEX Surgical Sealant in the extracorporeal repair of renal artery aneurysms","volume":"25","author":"Garcia\u2010Roig M.","year":"2011","journal-title":"Ann Vasc Surg"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.4103\/0970-1591.70574"},{"key":"e_1_2_9_16_2","unstructured":"Australian Public Assessment Report for Fibrin Sealant. Proprietary Product name: Artiss; Sponsor: Baxter Healthcare Pty Ltd.Commonwealth of Australia: Australian Department of Health and Ageing Therapeutic Goods Administration; October 2010:1\u201053."}],"container-title":["AORN Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0001209214006607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0001209214006607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/aornjournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1016\/j.aorn.2014.01.024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T06:40:36Z","timestamp":1695969636000},"score":1,"resource":{"primary":{"URL":"https:\/\/aornjournal.onlinelibrary.wiley.com\/doi\/10.1016\/j.aorn.2014.01.024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,26]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["10.1016\/j.aorn.2014.01.024"],"URL":"https:\/\/doi.org\/10.1016\/j.aorn.2014.01.024","archive":["Portico"],"relation":{},"ISSN":["0001-2092","1878-0369"],"issn-type":[{"value":"0001-2092","type":"print"},{"value":"1878-0369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,26]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemostatic Agents: A Guide to Safe Practice for Perioperative Nurses","name":"articletitle","label":"Article Title"},{"value":"AORN Journal","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.aorn.2014.01.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 AORN, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}